Source: Annual Congress 2001 - Exogenous surfactant administration for the treatment of acute lung injury
Disease area: Respiratory critical care



Rating:

Share or cite this content

Citations should be made in the following way:
K. Raymondos, J. Braun, M. Martin, T. Schmudlach, M. Brandes, D. Korth, B. Hillmer, W. Bernhard, H. C. Pape, S. Piepenbrock (Hannover, Lubeck, Germany). Exogenous surfactant administration in patients at high risk to develop ARDS after multiple trauma. Eur Respir J 2001; 16: Suppl. 31, 152

Member's Comments

No comment yet.

Related content which might interest you: Surfactant and inflammation in patients predisposed for ARDS after multiple trauma Source: Annual Congress 2004 - The fourth ERS - free paper symposium on interdisciplinary basic and clinical surfactant research Year: 2004 Exogenous pulmonary surfactant administration for acute respiratory distress syndrome in post-operative patients Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009 High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis Source: Eur Respir J, 50 (1) 1700013; 10.1183/13993003.00013-2017 Year: 2017 Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids Source: Eur Respir J 2001; 17: 337-342 Year: 2001 Plasma levels of LL37 in patients with and at risk of acute lung injury Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 Surfactant therapy - the real chance to survive for the patients with severe inhalation injury Source: Eur Respir J 2004; 24: Suppl. 48, 677s Year: 2004 Principles of surfactant-therapy ARDS in patients with severe inhalation trauma Source: Annual Congress 2008 - Acute lung injury and weaning Year: 2008 LSC Abstract – Effects of vitamin D supplementation on perioperative markers of inflammation in patients at risk of acute respiratory distress syndrome (ARDS) Source: International Congress 2016 – New therapies and therapeutic targets Year: 2016 Efficacy of surfactant-BL in treatment ARDS in patients with severe inhalation injury Source: Eur Respir J 2006; 28: Suppl. 50, 345s Year: 2006 Surfactant treatment leads to a sustained improvement of oxygenation only in severe pediatric ARDS without pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 318s Year: 2001 Importance of low-invasive monitoring for prevention of ARDS in patients with severe inhalation injury Source: Annual Congress 2008 - Mechanical ventilation and airway management Year: 2008 Systemic complications predict mask ventilation failure in elderly COPD patients with acute respiratory failure Source: Annual Congress 2007 - Acute respiratory failure and noninvasive mechanical ventilation Year: 2007 Exogenous surfactant in acute respiratory distress syndrome: more is better Source: Eur Respir J 2002; 19: 787-789 Year: 2002 The incidence and risk factors of ventilator associated pneumonia on the mortality in patients with traumatic brain injury Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Assessing the incidence pattern of pneumonia among COPD patients with or without exposure to inhaled steroids Source: Annual Congress 2007 - Epidemiology of COPD Year: 2007 High dose short course of inhaled corticosteroid administration may prevent home oxygen therapy in neonatal chronic lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 140s Year: 2003 Ability of the reduced severity rule crb-65 to detect high risk of short-term mortality from pneumonia in elderly patients Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Reduction of the systemic inflammatory response in patients with CAP treated with corticosteroids improves clinical outcome and reduces mortality and ICU admittance Source: Annual Congress 2011 - Pulmonary infections and sepsis Year: 2011 Reduction of in-hospital mortality in patients with acute exacerbation of interstitial pneumonia recognized after introduction of non-invasive ventilation Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008 G-CSF administration improves chronic lung disease caused by exposure to high-concentration oxygen in neonatal mice Source: Annual Congress 2012 - Issues in neonatal and paediatric intensive care Year: 2012